| JRSDX | VTSAX | JRSDX / VTSAX | |
| Total Expense Ratio | 0.70 | 0.04 | 1,750% |
| Annual Report Gross Expense Ratio | 0.70 | 0.04 | 1,750% |
| Fund Existence | 11 years | 25 years | - |
| Gain YTD | 0.674 | 0.895 | 75% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 622M | 2.06T | 0% |
| Annual Yield % from dividends | 0.56 | 1.09 | 51% |
| Returns for 1 year | 1.08 | 13.41 | 8% |
| Returns for 3 years | 30.61 | 63.25 | 48% |
| Returns for 5 years | 5.05 | 66.46 | 8% |
| Returns for 10 years | 62.82 | 269.14 | 23% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PJP | 108.71 | 1.82 | +1.70% |
| Invesco Pharmaceuticals ETF | |||
| STAX | 25.59 | N/A | N/A |
| Nomura Tax-Free USA Short Term ETF | |||
| ECNS | 34.51 | -0.13 | -0.36% |
| iShares MSCI China Small-Cap ETF | |||
| QGRD | 26.44 | -0.37 | -1.37% |
| Horizon NASDAQ-100 Defined Risk ETF | |||
| GPIQ | 51.62 | -0.81 | -1.54% |
| Goldman Sachs Nasdaq-100 Premium Inc ETF | |||